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Abstract 
Background: Dysmenorrhea is a prevalent pain condition among women and a risk factor for 
other chronic pain conditions. Individuals vary in dysmenorrhea pain severity, the number of 
painful sites, and co-occurring gastrointestinal symptoms. Three dysmenorrhea symptom-based 
phenotypes were previously identified using latent class analysis; however, there is a need to 
validate these in an independent sample, so they can be used in mechanistic and interventional 
research. There also is a need to further characterize dysmenorrhea symptom-based phenotypes 
in terms of demographic, clinical, and psychobehavioral characteristics so they can be used to 
inform precision dysmenorrhea treatment.  
Objectives: The study objectives were to: (a) determine whether the same dysmenorrhea 
symptom-based phenotypes would be found in a new sample; (b) determine whether including 
demographic, clinical, and psychobehavioral covariates in latent class analyses would change 
individuals’ phenotype memberships; and (c) investigate relationships between dysmenorrhea 
symptom-based phenotypes and demographic, clinical, and psychobehavioral characteristics. 
Methods: This cross-sectional survey study included 678 women (aged 14 to 42 years) with 
dysmenorrhea. Participants reported dysmenorrhea symptom severity, demographic, clinical 
(comorbid chronic pain and gynecological conditions), and psychobehavioral characteristics 
(perceived stress, anxiety, depression, sleep disturbance, and pain catastrophizing). We used 
latent class analysis to identify symptom-based phenotypes. We compared analyses with and 
without covariates (i.e., demographic, clinical, and psychobehavioral characteristics) to 
determine if individuals’ phenotype memberships changed. We then examined associations 
between phenotypes and demographic, clinical, and psychobehavioral characteristics. 
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Results: We reproduced three dysmenorrhea symptom-based phenotypes: the “mild localized 
pain” phenotype (characterized by mild abdominal cramps), the “severe localized pain” 
phenotype (characterized by severe abdominal cramps), and the “multiple severe symptoms” 
phenotype (characterized by severe pain at multiple locations and gastrointestinal symptoms). 
Analyses with and without covariates had little effect on individuals’ phenotype membership. 
Race, comorbid chronic pain condition, endometriosis, and pain catastrophizing were 
significantly associated with the dysmenorrhea phenotypes.  
Discussion: Findings provide a foundation to further study mechanisms of dysmenorrhea 
symptom heterogeneity and develop dysmenorrhea precision treatments. The three dysmenorrhea 
symptom-based phenotypes were validated in a second sample. Demographic, clinical, and 
psychobehavioral factors were associated with dysmenorrhea symptom-based phenotypes.  
 
Keywords: chronic pain, dysmenorrhea, menstruation, pelvic pain, phenotype 
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Dysmenorrhea Symptom-Based Phenotypes: A Replication and Extension Study 
 
Dysmenorrhea affects 45% to 95% of women of reproductive age or approximately 855 
million women worldwide (Iacovides et al., 2015; United Nations, Department of Economic and 
Social Affairs, Population Division, 2015). It can negatively affect women’s physical activity, 
sleep, and quality of life (Iacovides et al., 2015). Dysmenorrhea commonly occurs with other 
chronic pain conditions (e.g., irritable bowel syndrome [IBS], migraine, and noncyclic pelvic 
pain), can worsen other pain conditions, and may even increase women’s risk for developing 
other chronic pain conditions (Altman et al., 2006; Giamberardino, 2008; Olafsdottir et al., 2012; 
Vincent et al., 2011; Westling et al., 2013). 
Although dysmenorrhea is characterized by menstrual pain, significant inter-individual 
variability exists. Women have described variability in menstrual pain severity, the number of 
painful sites, and co-occurring gastrointestinal (GI) symptoms (Chen, Draucker et al., 2018; 
Heitkemper et al., 1988). Using latent class analysis, three distinct dysmenorrhea symptom-based 
phenotypes have been identified (Chen, Ofner et al., 2018). The first phenotype was “mild 
localized pain,” characterized by mild abdominal cramps and dull pain. The second phenotype 
was “severe localized pain,” wherein women experience severe abdominal cramps. The third 
phenotype was “multiple severe symptoms,” characterized by severe pain at multiple sites and 
severe GI symptoms (Chen, Ofner et al., 2018). In that study, women in different symptom-
based dysmenorrhea phenotypes varied in age, race/ethnicity, and the existence of comorbid 
chronic pain conditions.  
Despite progress in identifying and characterizing individual differences in dysmenorrhea 
symptomology, three gaps exist. First, it is unclear if prior findings regarding the existence of 
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three dysmenorrhea symptom-based phenotypes are reproducible. The previous study (Chen, 
Ofner et al., 2018) included only adult women aged 18 and above; thus, results need to be 
validated in samples that include younger women. Replication studies are needed in symptom 
phenotype research(Miaskowski et al.2007). Validating the previous findings in an independent 
sample is necessary so future research can use these phenotypes to study mechanisms and test 
differential treatment response.  
Second, it is unclear if individuals’ phenotype membership varies based on whether 
covariates (i.e., demographic, clinical, and psychobehavioral characteristics) are included in 
latent class analysis. Latent class analysis is increasingly used in symptom research to subgroup 
individuals (Miaskowski et al., 2007; Woods et al., 2016). While latent class analysis can be 
conducted with and without covariates, it is unclear whether including covariates affects 
individuals’ phenotype classification. In other words, it is unknown whether individual 
participants will be classified into different phenotype groups when covariates are included in the 
analysis. Are only the symptom data or both the symptom and other covariates data needed to 
phenotype individuals? Knowing the answer to this question can help researchers understand 
how best to measure phenotypes in the future. 
Third, psychobehavioral correlates of dysmenorrhea symptom-based phenotypes are 
unknown. Research suggests psychobehavioral characteristics (e.g., perceived stress, depression, 
anxiety, sleep disturbance, and pain catastrophizing) may be associated with individual 
differences in chronic pain (Edwards et al., 2006; Fillingim, 2017; Phillips & Clauw, 2011). 
Individuals with widespread pain commonly reported high levels of perceived stress (Lai et al., 
2017). Depression and anxiety commonly co-occur with chronic pain—especially widespread 
pain (Phillips & Clauw, 2011). Sleep disturbance has a bidirectional relationship with chronic 
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pain; it can be the result of chronic pain as well as a risk factor for chronic pain (Finan et al., 
2013). Lastly, pain catastrophizing, or maladaptive thoughts and feelings about pain 
characterized by catastrophic thinking and feeling helpless, predicts the severity and number of 
pain locations in other pain conditions (Schanberg et al., 1997; Sullivan et al., 2001). In the 
context of dysmenorrhea, research suggests psychobehavioral characteristics are associated with 
individual differences in menstrual pain severity (Payne et al., 2016; Sahin et al., 2018; Walsh et 
al., 2003). For example, Walsh et al. (2003) found that high pain catastrophizers reported more 
severe menstrual pain compared to low pain catastrophizers. However, the association between  
symptom-based dysmenorrhea phenotypes and psychobehavioral characteristics has yet to be 
explored. Further characterizing symptom-based dysmenorrhea phenotypes in terms of 
demographic, clinical, and psychobehavioral variables is a prerequisite to using phenotypes to 
guide precision dysmenorrhea treatment.  
The aims of this study were to: (a) replicate prior study findings in an independent 
sample that included younger women; (b) compare analyses with and without covariates to 
determine if individuals’ phenotype memberships changed; and (c) investigate associations 
between symptom-based dysmenorrhea phenotypes and demographic, clinical, and 
psychobehavioral characteristics.    
Methods 
Design and Participants 
This was a cross-sectional descriptive study. We used data from 678 participants with 
dysmenorrhea who participated in an online survey. Data collection occurred between January 
and March of 2019.  
Eligibility criteria were: (a) female; (b) age 14–42 years old; (c) living in the United 
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States; (d) able to read and write English; and (d) self-identified as having had abdominal cramps 
and other symptoms just before or during a menstrual period (e.g., low back pain, headache, 
bloating, nausea, diarrhea, or more bowel movements than usual) in the last 6 months. 
Participants were recruited from online survey panels maintained by the panel provider, 
Qualtrics (Qualtrics, Provo, UT). Online survey panels consisted of individuals willing to be 
contacted for internet surveys. The online survey panel providers typically recruited panel 
participants through internet banner ads, mail or emails, or by word of mouth (Baker et al., 
2010).  
Procedures 
The institutional review board at the Indiana University approved this study. The survey 
panel provider used registrants’ demographic data on file to select potential participants and sent 
an email notification about the study to this pre-identified group. For those interested in 
participating, they proceeded by clicking the hyperlink to the survey embedded in the email 
message. Potential participants were further screened and those who met eligibility criteria were 
directed to the study information page (i.e., the implied consent form). Those who agreed to 
participate proceeded to the survey questionnaires.  
To ensure data quality, we used three attention filters (i.e., “trap questions”) buried in the 
online survey. We excluded data from those who failed any of the attention filters. In addition, 
we excluded data from respondents who spent less than one third of the overall group’s median 
time to complete the survey.  
Measurement 
Dysmenorrhea Symptom Severity 
Participants rated the severity of 14 dysmenorrhea-related symptoms: abdominal cramps, 
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dull abdominal pain or discomfort, low back pain, pain in the upper thighs, headache or 
migraines, pain when the bladder was full, aches all over, bloating, nausea, vomiting, diarrhea 
(loose stools), constipation (hard stools), more bowel movements than usual, and fewer bowel 
movements than usual. The list of symptoms was based on a literature review of dysmenorrhea 
symptom measures (Chen et al., 2015). Participants rated the severity of each symptom on a 0 
(“not present”) to 10 (“extremely severe”) scale. Each severity rating was then categorized into 
one of four groups based on established cut points: no symptom (0), mild (1–4), moderate (5–6), 
and severe (7–10; Serlin et al., 1995). Table 1 summarizes the covariates we used in the latent 
class analyses and provides descriptions of their corresponding measures.  
Demographic and Clinical Covariates 
We collected demographic (age, race, ethnicity) and self-reported clinical data on 
comorbid chronic pain and gynecological conditions. For comorbid chronic pain conditions, 
participants reported if they had any of the following: back pain, IBS, migraines, nonmigraine 
headaches, fibromyalgia, neck pain, pelvic pain outside of the menstrual period, interstitial 
cystitis, and/or other chronic pain. For gynecological conditions, participants reported whether a 
health provider had ever diagnosed them with endometriosis, uterine fibroids, bacterial 
vaginosis, and/or polycystic ovary syndrome. These conditions have been linked to 
dysmenorrhea (Berkley, 2013; Li et al., 2014).  
Psychobehavioral Covariates  
We assessed psychobehavioral characteristics, including perceived stress, depression, 
anxiety, sleep disturbance, and pain catastrophizing. Each of the measures described below has 
demonstrated appropriate reliability and validity. 
Perceived stress was measured with the Perceived Stress Scale (Cohen et al., 1983). The 
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questions in the scale asked participants about their thoughts and feelings during the last month. 
Participants rated each of 10-items on a 5-point (0–4) scale, with higher scores indicating higher 
perceived stress.  
The Patient-Reported Outcomes Measurement Information System (PROMIS) 
depression, anxiety, and sleep disturbance short-form scales were used to measure these 
respective symptoms (Pilkonis et al., 2011; Yu et al., 2012). On each 8-item measure, 
participants rated the severity of their symptoms during the past seven days on a 5-point (1–5) 
scale. Raw scale scores were converted to T-scores using a conversion table (more information 
can be found at www.healthmeasures.net). A score of 50 is the average for the United States 
general population, and 10 is the standard deviation. Higher T-scores indicated more severe 
depression, anxiety, or sleep disturbance. Table 1 lists the range of each PROMIS short form.  
Pain catastrophizing was measured with the 13-item Pain Catastrophizing Scale (Sullivan 
et al., 1995). On a scale from 0–4, participants rated the extent to which they worry, amplify, and 
feel helpless about the experience of pain. Higher scores suggested greater pain catastrophizing.  
Data Analysis  
Descriptive statistics were used to summarize participants’ demographic, clinical, and 
psychobehavioral characteristics.  
Aim 1: Reproducing Dysmenorrhea Symptom-Based Phenotypes 
We used latent class analysis to replicate previous research (Chen, Ofner, et al., 2018). 
Similar to the prior study, we fit the latent class model using the one-step method—in which we 
regressed the latent variable (i.e., symptom-based phenotypes) on the covariates (i.e., 
demographic, clinical, and psychobehavioral variables)—while simultaneously estimating the 
latent class using the dysmenorrhea symptom severity data.  
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The number of phenotypes (i.e., latent classes) was determined based on model fit and 
model usefulness. We assessed model fit by inspecting values of the Bayesian information 
criterion ([BIC], lower value, better fit) and Akaike information criterion ([AIC], lower value, 
better fit). We assessed model usefulness by inspecting the measure of entropy (with a goal of 
0.8 or above) and the interpretability of the latent class solution. Among solutions with entropy 
values of 0.8 and above, the solution with the lowest AIC and lowest BIC was selected. The 
interpretation of each phenotype was based on examining posterior probabilities. Specifically, 
for each symptom, the sum of Manhattan distances between the posterior probabilities and 0.25 
was calculated. When the sum is 0.4 and above, the symptom was unevenly distributed across 
the four severity categories (none, mild, moderate, severe; Chen, Ofner, et al., 2018). For these 
symptoms, the severity category with the largest probability was used to interpret the phenotype.  
Aim 2: Comparing Analyses With and Without Covariates to Determine if Individuals’ 
Phenotype Memberships Changed 
We constructed three latent class models: empty model (i.e., model without covariates); 
partial model (i.e., with demographic and clinical covariates); and full model (i.e., with 
demographic, clinical, and psychobehavioral covariates). For each model, individual participants 
were assigned to a phenotype based on probabilities. To determine if three models would result 
in different phenotype assignment for a given individual, we compared individuals’ phenotype 
memberships across three models. Specifically, we checked the consistency among models for 
phenotype assignment by calculating the percentage of perfect agreement in latent class 
membership among models. 
Aim 3: Associations Between Phenotypes and Demographic, Clinical, and Psychobehavioral 
Characteristics 
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To examine associations between phenotypes and covariates (i.e., demographic, clinical, 
and psychobehavioral characteristics), we used the one-step latent class model estimation 
approach in which the phenotypes were estimated and regressed on covariates simultaneously 
(Bolck et al., 2004). This one-step approach overcomes the biased-estimation issue associated 
with the traditional three-step approach (Bolck et al., 2004). Strengths and directions of 
associations between covariates and latent class membership were quantified with odds ratios 
(ORs) and 95% confidence intervals. We used Mplus (V6.1) for the latent class analysis and 
SAS/STAT (V9.4) software (Cary, NC) for other analyses. 
Results 
Sample Characteristics  
Table 2 shows the demographic, clinical, and psychobehavioral characteristics of the 
sample. The mean age of the sample was 28.0 years (SD = 7.6; range = 14–42). Among the 
participants, 71(10.5%) were adolescents younger than 18 years old. Most were White (67.7%) 
and non-Hispanic/non-Latino (87.9%). More than half (57.2%) had another chronic pain 
condition, including low back pain (31.7%), migraine headaches (28.8%), neck pain (13.9%), 
nonmigraine headaches (10.2%), pelvic pain occurring outside of menstrual period (9.7%), and 
IBS (8.3%). Some participants had been diagnosed with one or more gynecological conditions, 
including bacterial vaginosis (9.1%), endometriosis (4.9%), polycystic ovary syndrome (4.9%), 
and uterine fibroids (3.1%).  
Aim 1: Reproducing Dysmenorrhea Symptom-Based Phenotypes 
For the latent class model with demographic and clinical covariates, the three-class 
solution had a better model fit (lowest BIC and AIC) and represented a more interpretable 
classification of individual participants (entropy = 0.8). Based on the posterior probabilities, the 
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interpretation of the three phenotypes was largely consistent with previous research (Chen, 
Ofner, et al., 2018). The “mild localized pain” phenotype was characterized by mild abdominal 
cramps (posterior probabilities = 0.4 for the mild category) with few other symptoms. The 
“severe localized pain” phenotype was characterized by severe abdominal cramps (posterior 
probability = 0.5 for the severe category). The “multiple severe symptoms” phenotype was 
characterized by severe symptoms at multiple sites, including severe abdominal cramps 
(posterior probability = 0.8 for the severe category), severe menstrual low back pain (posterior 
probability = 0.6 for the severe category), severe menstrual headache or migraine (posterior 
probability = 0.6 for the severe category), and severe bloating (posterior probability = 0.6 for the 
severe category).  
Aim 2: Comparing Analyses With and Without Covariates to Determine if Individuals’ 
Phenotype Memberships Changed 
As shown in Table 3, the phenotype membership assignment was largely consistent 
across the three latent class models (i.e., empty, partial, and full). Among the three models, 
perfect agreement for phenotype membership assignment was above 94%. Therefore, 
individuals’ phenotype memberships rarely differed when covariates were included or excluded, 
suggesting that using only symptom data for defining phenotype membership (i.e., the most 
parsimonious model) was an appropriate choice.  
Aim 3: Associations Between Phenotypes and Demographic, Clinical, and 
Psychobehavioral Characteristics 
As shown in Table 4, certain demographic, clinical, and psychobehavioral characteristics 
were significantly associated with phenotypes. With regard to demographic characteristics, race 
was significantly associated with phenotype groups. The odds of Black/African American 
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women being in the “multiple severe symptoms” phenotype group versus the “mild localized 
pain” phenotype group were 2.43 times greater than those of White women (p = 0.041). 
Similarly, the odds of Black/African American women being in the “multiple severe symptoms” 
phenotype group versus the “severe localized pain” phenotype group were 3.78 times greater (p 
= .005).  
For clinical characteristics, the number of comorbid chronic pain conditions and a 
diagnosis of endometriosis were associated with dysmenorrhea phenotypes. For every additional 
increase in the number of chronic pain conditions, the odds of being in the “multiple severe 
symptoms” phenotype group versus the “mild localized pain” phenotype group increased by 59% 
(OR = 1.59, p = .001). A diagnosis of endometriosis increased the odds of being in the “multiple 
severe symptoms” phenotype group versus the “mild localized pain” phenotype 14.8 times (OR 
= 14.78, p = .018).  
For psychobehavioral characteristics, pain catastrophizing was associated with 
dysmenorrhea phenotypes. For a one unit increase in pain catastrophizing score, the odds of 
being in the “multiple severe symptoms” phenotype group versus the “mild localized pain” 
phenotype group increased by 6% (OR = 1.06, p < .001). Similarly, the odds of being in the 
“multiple severe symptoms” phenotype group versus the “severe localized pain” phenotype 
group increased by 4% for each unit increase in the pain catastrophizing score (OR = 1.04, p = 
.002). 
Discussion 
 In this study of 678 women with dysmenorrhea, we replicated and extended previous 
research on dysmenorrhea symptom-based phenotypes. Specifically, we reproduced previous 
findings on three dysmenorrhea symptom-based phenotypes, compared analyses with and 
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without covariates to determine if individuals’ phenotype memberships changed, and 
investigated the associations between dysmenorrhea symptom-based phenotypes and 
demographic, clinical, and psychobehavioral characteristics. 
Following the recommendation of symptom scientists (Miaskowski et al., 2007) and the 
National Institute of Health initiative to enhance the reproducibility of scientific findings (Colins 
& Tabak, 2014), we used an independent sample that included younger women to replicate the 
previous study on dysmenorrhea symptom-based phenotypes. Consistent with a previous study 
(Chen, Ofner, et al., 2018), we identified three dysmenorrhea symptom-based phenotypes, which 
were consistent with the previous findings. The previous study included only adult women, while 
this study included adolescents aged 14 to 17. In addition, there were higher percentages of 
women who were Asian, Black/African American, and Hispanic in the current study. This study 
provides additional evidence for the validity of dysmenorrhea symptom-based phenotypes. We 
encourage other researchers to independently replicate the study. Cumulative evidence will allow 
researchers to incorporate symptom-based phenotypes to study dysmenorrhea mechanisms and 
examine differential treatment responsiveness.  
We also found that including demographic, clinical, and psychobehavioral covariates in 
the latent class analysis did not significantly affect individuals’ phenotype classification. In other 
words, including covariates in the latent class analysis did not significantly affect how individual 
participants were grouped. Latent class analysis has been increasingly used in symptom research 
to subgroup individuals (Miaskowski et al., 2007). There has been little discussion about whether 
including covariates in latent class analysis affects participants’ classification. Based on this 
study, symptom severity data alone, without covariates, can be used to classify individuals into 
different symptom-based phenotypes, which simplifies the measurement of the phenotypes. 
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These findings should be further replicated in populations with other health conditions.  
This study expands upon previous research on dysmenorrhea symptom heterogeneity 
(Chen, Ofner et al., 2018; Heitkemper et al., 1991) and elucidates demographic, clinical, and 
psychobehavioral correlates of dysmenorrhea phenotypes. While including these correlates in 
latent class analysis did not change individuals’ phenotype classification, demographic, clinical, 
and psychobehavioral factors were associated with symptom-based dysmenorrhea phenotypes. 
Specifically, we found that race, the number of comorbid chronic pain conditions, diagnosis of 
endometriosis, and pain catastrophizing were significantly associated with symptom-based 
dysmenorrhea phenotypes. These data can help target and tailor treatments.  
The literature on racial and ethnic differences in dysmenorrhea has been limited. We 
found that women who were Black or African American were less likely to be in the “mild 
localized pain” phenotype group. Racial differences in menstruation have been reported in 
previous research. Black or African American women have higher heavy bleeding episodes than 
White women (Harlow & Campbell, 1996). In various pain conditions, race differences in 
prevalence and outcomes of chronic pain also have been reported (Campbell & Edwards, 2012). 
African Americans, compared to non-Hispanic Whites, suffer a greater burden of pain (Campbell 
& Edwards, 2012). The racial differences could be attributed to biological (e.g., genetic factors 
influencing pain sensitivity), psychological (e.g., depression and other psychological stress), and 
social factors (discrimination, access to effective treatments; Campbell & Edwards, 2012). 
Future research is needed to understand biopsychosocial mechanisms underlying the racial 
differences in dysmenorrhea symptomology.  
Our findings provide additional evidence that dysmenorrhea is associated with other 
chronic pain conditions (Altman et al., 2006; Hellman et al., 2018; Iacovides et al., 2015; 
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Olafsdottir et al., 2012; Westling et al., 2013). Consistent with a previous study (Chen, Ofner et 
al., 2018), we found that having comorbid pain was associated with a greater likelihood of a 
more severe dysmenorrhea phenotype. Increasing evidence suggests that women with 
dysmenorrhea have elevated pain sensitivity (Iacovides et al., 2015). Multiple studies have 
shown that women with moderate-to-severe dysmenorrhea exhibit abnormal structural and 
functional changes in the areas of the brain involved in pain processing (Tu et al., 2010; Vincent 
et al., 2011). These changes may increase women’s risk of developing chronic pain (Iacovides et 
al., 2015). Throughout the menstrual cycle, women with dysmenorrhea have increased pain 
sensitivity; therefore, dysmenorrhea has been classified as a type of central sensitivity syndrome 
(Iacovides et al., 2015). Central sensitization—characterized by heightened sensitivity to pain in 
multiple sites—may explain the higher prevalence and number of chronic pain conditions among 
participants in the “multiple severe symptoms” phenotype group.  
A diagnosis of endometriosis was associated with symptom-based dysmenorrhea 
phenotypes. Previous research has suggested that women with endometriosis were more likely to 
report severe menstrual pain than those without (Apostolopoulos et al., 2016). It is likely that 
endometriosis results in inflammation, which in turn exacerbates dysmenorrhea symptoms 
(Apostolopoulos et al., 2016). It is important to note that the association between endometriosis 
and dysmenorrhea symptomology has not always been supported. In a previous study, having 
endometriosis did not differentiate symptom-based dysmenorrhea phenotypes (Chen, Ofner et 
al., 2018). Other studies have shown little association between endometriosis pelvic pathology 
and dysmenorrhea symptoms (Gruppo Italiano per lo Studio dell’Endometriosi, 2001; Vercellini 
et al., 2007). Different study populations and different levels of diagnostic certainties may 
explain the inconsistent findings.  
  18 
 
 Our study showed that symptom-based dysmenorrhea phenotypes were associated with 
psychobehavioral factors, specifically pain catastrophizing. The effect sizes of the association 
were small, which is likely due to the small unit of measurement for the pain catastrophizing 
scale. In our analysis, instead of dichotomizing the pain catastrophizing variable, we treated it as 
a continuous variable with a possible range of 0–52. It also remains unclear whether the 
association is clinically meaningful. In a previous study by Walsh et al. (2003), high pain 
catastrophizers reported more severe menstrual pain compared to low pain catastrophizers. The 
relationship between psychological factors and dysmenorrhea symptomology likely is 
bidirectional. Psychological factors, such as pain catastrophizing, have been shown to increase 
the risk of developing chronic pain (Edwards et al., 2016). At the same time, repeated severe 
menstrual pain may increase women’s risk for negative cognitive and affective responses to pain 
(Liu et al., 2016), as imaging studies have shown that women with dysmenorrhea have abnormal 
connectivity between brain regions (e.g., hippocampus, medial prefrontal cortex, amygdala) 
involved in emotional processing (Liu et al., 2016; Tu et al., 2010).  
This study has several implications for future research. First, our findings have 
implications for identifying and characterizing symptom-based phenotypes in other health 
conditions. Including covariates in a latent class analysis will result in more reliable estimates for 
covariates and phenotype associations without significantly altering individuals’ phenotype 
membership. Second, longitudinal studies are needed to elucidate the relationships between 
dysmenorrhea phenotypes and other chronic pain conditions. For example, women in the 
“multiple severe symptoms” phenotype group may have a higher risk of developing future pain 
and might be appropriately targeted for more comprehensive and intensive treatment. Similarly, 
longitudinal studies may shed light on the relationship between dysmenorrhea phenotypes and 
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psychobehavioral factors. Second, exploring other factors that explain dysmenorrhea symptom 
heterogeneity is warranted. Researchers can consider additional biopsychosocial processes 
known to contribute to individual differences in pain (e.g., genetics, traumatic experiences; 
Fillingim, 2017) and explore interactions between those factors. The knowledge gained from this 
research could serve as the basis for developing precision treatment for dysmenorrhea.  
This study also has implications for clinical practice. First, individual differences in 
dysmenorrhea suggest a “one-size-fits-all” approach to dysmenorrhea treatment could be 
inefficient and ineffective. Clinicians mostly treat dysmenorrhea with pharmacotherapy, such as 
nonsteroidal inflammatory drugs, while 18% of women with dysmenorrhea do not respond to 
nonsteroidal inflammatory drugs (Owen, 1984). Data in this paper suggest that, for individuals 
with severe dysmenorrhea symptoms, a more complex combination of therapies may be 
promising. Second, clinicians need to be aware of the racial differences in dysmenorrhea and its 
likely multifactorial mechanisms. Research suggests that perceptions of discrimination is 
prevalent among African Americans with chronic pain and contributes to negative outcomes of 
chronic pain (Campbell & Edwards, 2012). Clinicians need to make an effort to reflect implicit 
bias when treating patients and reduce disparity in outcomes of dysmenorrhea and other chronic 
pain conditions. Third, clinicians should be aware of the linkage between dysmenorrhea and 
other chronic pain conditions so that they can screen for pain conditions and treat women 
appropriately. It is important to screen for other chronic pain conditions among women with 
dysmenorrhea, especially those with more systematic symptoms (menstrual pain at multiple sites 
and menstrual GI symptoms). In so doing, clinicians can treat conditions that might improve 
dysmenorrhea management. Conversely, treating dysmenorrhea may reduce symptoms 
associated with other chronic pain conditions (Giamberardino, 2008). Fourth, the associations 
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between dysmenorrhea phenotypes and psychobehavioral factors suggest the need to screen for 
dysmenorrhea among women with high pain catastrophizing. Likewise, among women who have 
more severe, widespread menstrual pain and menstrual GI symptoms, it can be valuable to screen 
for pain catastrophizing. Interventions targeting pain catastrophizing may help relieve 
dysmenorrhea symptoms for some women.  
Limitations 
 This study had limitations. First, the study was cross-sectional, preventing conclusions 
about causality. We do not know with certainty if specific dysmenorrhea phenotypes increase 
women’s risk for future pain or if having another chronic pain condition exacerbates 
dysmenorrhea symptoms. The same uncertainty is true for the relationship between 
dysmenorrhea phenotypes and pain catastrophizing. Second, there could be recall bias in survey 
responses. Third, clinical data were self-reported; gynecological conditions were not verified. 
The gold standard for confirmatory diagnosis of endometriosis is laparoscopic inspection with 
histologic confirmation after biopsy, making confirmatory diagnosis ethically and logistically 
challenging for a large population-based study. Despite these limitations, we recruited a 
relatively large and diverse sample in terms of age, race, and ethnicity, and we enhanced data 
quality by excluding participants who had failed attention filters or took less than one third of the 
group’s median time to complete the survey. 
Conclusion 
We reproduced the three dysmenorrhea symptom-based phenotypes and found certain 
demographic, clinical, and psychobehavioral factors were associated with dysmenorrhea 
symptom-based phenotypes. Findings provide a foundation to further study mechanisms of 
dysmenorrhea symptom heterogeneity and develop dysmenorrhea precision treatments. 
 
  21 
 
References 
Altman, G., Cain, K. C., Motzer, S., Jarrett, M., Burr, R., & Heitkemper, M. (2006). Increased 
symptoms in female IBS patients with dysmenorrhea and PMS. Gastroenterology 
Nursing, 29, 4-11. https://doi.org/10.1097/00001610-200601000-00002 
Apostolopoulos, N. V., Alexandraki, K. I., Gorry, A., & Coker, A. (2016). Association between 
chronic pelvic pain symptoms and the presence of endometriosis. Archives of Gynecology 
and Obstetrics, 293, 439-445. https://doi.org/10.1007/s00404-015-3855-2 
Baker, R., Blumberg, S. J., Brick, J. M., Couper, M. P., Courtright, M., Dennis, J. M., Dillman, 
D., Frankel, M. R, Garland, P., Groves, R. M., Kennedy, C., Krosnick, J., Lavrakas, P. J., 
Lee, S., Link, M., Piekarski, L, Rao, K., Thomas, R. K., Zahs, D. (2010). Research 
synthesis: AAPOR report on online panels. Public Opinion Quarterly, 74, 711-781. 
https://doi.org/10.1093/poq/nfq048 
Berkley, K. J. (2013). Primary dysmenorrhea: an urgent mandate. Pain, 21(3), 1-8. 
https://www.iasp-pain.org/PublicationsNews/NewsletterIssue.aspx?ItemNumber=2062Bolck, 
A., Croon, M., & Hagenaars, J. (2004). Estimating latent structure models with 
categorical variables: One-step versus three-step estimators. Political Analysis, 12, 3-27. 
https://doi.org/10.1093/pan/mph001 
Campbell, C. M., & Edwards, R. R. (2012). Ethnic differences in pain and pain 
management. Pain Management, 2, 219-230. https://doi.org/10.2217/pmt.12.7 
Collins, F. S., & Tabak, L. A. (2014). Policy: NIH plans to enhance reproducibility. Nature, 505, 
612-613. https://doi.org/10.1038/505612a 
  22 
 
Chen, C. X., Draucker, C. B., & Carpenter, J. S. (2018). What women say about their 
dysmenorrhea: A qualitative thematic analysis. BMC Women’s Health, 18, 47. 
https://doi.org/10.1186/s12905-018-0538-8 
Chen, C. X., Kwekkeboom, K. L., & Ward, S. E. (2016). Beliefs About Dysmenorrhea and Their 
Relationship to Self-Management. Research in nursing & health, 39(4), 263–276. 
https://doi.org/10.1002/nur.21726 
Chen, C. X., Ofner, S., Bakoyannis, G., Kwekkeboom, K. L., & Carpenter, J. S. (2018). 
Symptoms-based phenotypes among women with dysmenorrhea: A latent class 
analysis. Western Journal of Nursing Research, 40, 1452-1468. 
https://doi.org/10.1177/0193945917731778 
Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress.  
Journal of Health and Social Behavior, 24, 385-396. https://doi.org/10.2307/2136404 
Edwards, R. R., Bingham, C. O., III, Bathon, J., & Haythornthwaite, J. A. (2006). 
Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis 
Care & Research, 55, 325-332. https://doi.org/10.1002/art.21865 
Fillingim, R. B. (2017). Individual differences in pain: Understanding the mosaic that makes 
pain personal. Pain, 158, S11-S18. https://doi.org/10.1097/j.pain.0000000000000775 
Finan, P. H., Goodin, B. R., & Smith, M. T. (2013). The association of sleep and pain: An update 
and a path forward. Journal of Pain, 14, 1539-1552. 
https://doi.org/10.1016/j.jpain.2013.08.007 
Giamberardino, M. A. (2008). Women and visceral pain: Are the reproductive organs the main 
protagonists? Mini-review at the occasion of the “European Week Against Pain in 
Women 2007.” European Journal of Pain, 12, 257-260. 
https://doi.org/10.1016/j.ejpain.2007.11.007 
  23 
 
Gruppo Italiano per lo Studio dell’Endometriosi. (2001). Relationship between stage, site and 
morphological characteristics of pelvic endometriosis and pain. Human Reproduction, 16, 
2668-2671. https://doi.org/10.1093/humrep/16.12.2668 
Harlow, S. D., & Campbell, B. (1996). Ethnic differences in the duration and amount of 
menstrual bleeding during the postmenarcheal period. American Journal of 
Epidemiology, 144, 980-988. https://doi.org/10.1093/oxfordjournals.aje.a008868 
Heitkemper, M., Jarrett, M., Bond, E. F., & Turner, P. (1991). GI symptoms, function, and 
psychophysiological arousal in dysmenorrheic women. Nursing Research, 40, 20-26. 
https://doi.org/10.1097/00006199-199101000-00005 
Heitkemper, M. M., Shaver, J. F., & Mitchell, E. S. (1988). Gastrointestinal symptoms and 
bowel patterns across the menstrual-cycle in dysmenorrhea. Nursing Research, 37, 108-
113. https://doi.org/10.1097/00006199-198803000-00011 
Hellman, K. M., Datta, A., Steiner, N. D., Morlock, J. N. K., Garrison, E. F., Clauw, D. J., & Tu, 
F. F. (2018). Identification of experimental bladder sensitivity among dysmenorrhea 
sufferers. American Journal of Obstetrics & Gynecology, 219, 84.e1-84.e8. 
https://doi.org/10.1016/j.ajog.2018.04.030 
Iacovides, S., Avidon, I., & Baker, F. C. (2015). What we know about primary dysmenorrhea 
today: A critical review. Human Reproduction Update, 21, 762–778. 
https://doi.org/10.1093/humupd/dmv039 
Lai, H. H., Jemielita, T., Sutcliffe, S., Bradley, C. S., Naliboff, B., Williams, D. A., Gereau, R. 
W., Kreder, K., Clemens, J. Q., Rodriguez, L. V., Krieger, J. N., Farrar, J. T., Robinson, 
N., & Landis, J. R. (2017). Characterization of whole body pain in urological chronic 
pelvic pain syndrome at baseline: A MAPP Research Network Study. Journal of 
Urology, 198, 622-631. https://doi.org/10.1016/j.juro.2017.03.132 
  24 
 
Li, X.-D., Wang, C.-C., Zhang, X.-J., Gao, G.-P., Tong, F., Li, X., Hou, S., Sun, L., & Sun, Y.-
H. (2014). Risk factors for bacterial vaginosis: Results from a cross-sectional study 
having a sample of 53,652 women. European Journal of Clinical Microbiology & 
Infectious Diseases, 33, 1525-1532. https://doi.org/10.1007/s10096-014-2103-1 
Liu, P., Wang, G., Liu, Y., Yu, Q., Yang, F., Jin, L., Sun, J., Yang, X., Qin, W., & Calhoun, V. 
D. (2016). White matter microstructure alterations in primary dysmenorrhea assessed by 
diffusion tensor imaging. Scientific Reports, 6, 25836. https://doi.org/10.1038/srep25836 
Miaskowski, C., Aouizerat, B. E., Dodd, M., & Cooper, B. (2007). Conceptual issues in 
symptom clusters research and their implications for quality-of-life assessment in patients 
with cancer. Journal of the National Cancer Institute Monographs, 37, 39-46. 
https://doi.org/10.1093/jncimonographs/lgm003 
Olafsdottir, L. B., Gudjonsson, H., Jonsdottir, H. H., Björnsson, E., & Thjodleifsson, B. (2012). 
Natural history of irritable bowel syndrome in women and dysmenorrhea: A 10-year 
follow-up study. Gastroenterology Research and Practice, 2012, 534204. 
https://doi.org/10.1155/2012/534204 
Owen, P. R. (1984). Prostaglandin synthetase inhibitors in the treatment of primary 
dysmenorrhea: Outcome trials reviewed. American Journal of Obstetrics & 
Gynecology, 148, 96-103. https://doi.org/10.1016/s0002-9378(84)80039-3 
Payne, L. A., Rapkin, A. J., Lung, K. C., Seidman, L. C., Zeltzer, L. K., & Tsao, J. C. I. (2016). 
Pain catastrophizing predicts menstrual pain ratings in adolescent girls with chronic pain. 
Pain Medicine, 17, 16-24. https://doi.org/10.1111/pme.12869 
  25 
 
Phillips, K., & Clauw, D. J. (2011). Central pain mechanisms in chronic pain states—Maybe it is 
all in their head. Best Practice & Research Clinical Rheumatology, 25, 141-154. 
https://doi.org/10.1016/j.berh.2011.02.005 
Pilkonis, P. A., Choi, S. W., Reise, S. P., Stover, A. M., Riley, W. T., Cella, D., & PROMIS 
Cooperative Group. (2011). Item banks for measuring emotional distress from the 
Patient-Reported Outcomes Measurement Information System (PROMIS®): Depression, 
anxiety, and anger. Assessment, 18, 263-283. https://doi.org/10.1177/1073191111411667 
Sahin, N., Kasap, B., Kirli, U., Yeniceri, N., & Topal, Y. (2018). Assessment of anxiety–
depression levels and perceptions of quality of life in adolescents with dysmenorrhea. 
Reproductive Health, 15, 13. https://doi.org/10.1186/s12978-018-0453-3 
Serlin, R. C., Mendoza, T. R., Nakamura, Y., Edwards, K. R., & Cleeland, C. S. (1995). When is 
cancer pain mild, moderate or severe? Grading pain severity by its interference with 
function. Pain, 61, 277-284. https://doi.org/10.1016/0304-3959(94)00178-h 
Schanberg, L. E., Lefebvre, J. C., Keefe, F. J., Kredich, D. W., & Gil, K. M. (1997). Pain coping 
and the pain experience in children with juvenile chronic arthritis. Pain, 73, 181-189. 
https://doi.org/10.1016/s0304-3959(97)00110-3 
Sullivan, M. J., Thorn, B., Haythornthwaite, J. A., Keefe, F., Martin, M., Bradley, L. A., & 
Lefebvre, J. C. (2001). Theoretical perspectives on the relation between catastrophizing 
and pain. Clinical Journal of Pain, 17, 52-64. https://doi.org/10.1097/00002508-
200103000-00008 
Sullivan, M. J. L., Bishop, S. R., & Pivik, J. (1995). The Pain Catastrophizing Scale: 
Development and validation. Psychological Assessment, 7, 524-532. 
https://doi.org/10.1037/1040-3590.7.4.524 
  26 
 
Tu, C.-H., Niddam, D. M., Chao, H.-T., Chen, L.-F., Chen, Y.-S., Wu, Y.-T., Yeh, T.-C., Lirng, 
J.-F., & Hsieh, J.-C. (2010). Brain morphological changes associated with cyclic 
menstrual pain. Pain, 150, 462-468. https://doi.org/10.1016/j.pain.2010.05.026 
United Nations, Department of Economic and Social Affairs, Population Division. (2015). 
Population 2030: Demographic challenges and opportunities for sustainable 
development planning (ST/ESA/SER.A/389). Retrieved from 
http://www.un.org/en/development/desa/population/publications/pdf/trends/Population2030
.pdf 
Vercellini, P., Fedele, L., Aimi, G., Pietropaolo, G., Consonni, D., & Crosignani, P. G. (2007). 
Association between endometriosis stage, lesion type, patient characteristics and severity 
of pelvic pain symptoms: A multivariate analysis of over 1000 patients. Human 
Reproduction, 22, 266-271. https://doi.org/10.1093/humrep/del339 
Vincent, K., Warnaby, C., Stagg, C. J., Moore, J., Kennedy, S., & Tracey, I. (2011). 
Dysmenorrhoea is associated with central changes in otherwise healthy women. Pain, 
152, 1966-1975. https://doi.org/10.1016/j.pain.2011.03.029 
Walsh, T. M., LeBlanc, L., & McGrath, P. J. (2003). Menstrual pain intensity, coping, and 
disability: The role of pain catastrophizing. Pain Medicine, 4, 352-361. 
https://doi.org/10.1111/j.1526-4637.2003.03039.x 
Woods, N. F., Hohensee, C., Carpenter, J. S., Cohen, L., Ensrud, K., Freeman, E. W., Guthrie, K. 
A., Joffe, H., LaCroix, A. Z., & Otte, J. L. (2016). Symptom clusters among MsFLASH 
clinical trial participants. Menopause, 23, 158-165. 
https://doi.org/10.1097/GME.0000000000000516 
Westling, A. M., Tu, F. F., Griffith, J. W., & Hellman, K. M. (2013). The association of 
dysmenorrhea with noncyclic pelvic pain accounting for psychological factors. American 
  27 
 
Journal of Obstetrics & Gynecology, 209, 422.e1-422.e10. 
https://doi.org/10.1016/j.ajog.2013.08.020 
Yu, L., Buysse, D. J., Germain, A., Moul, D. E., Stover, A., Dodds, N. E., Johnston, K. L., & 
Pilkonis, P. A. (2012). Development of short forms from the PROMIS™ sleep 
disturbance and sleep-related impairment item banks. Behavioral Sleep Medicine, 10, 6-
24. https://doi.org/10.1080/15402002.2012.636266 
 









Variable Name Item Options Scale Summary Score 
Demographic  Age  Interval   
Race  
 
1) White  
2) Black or African American 
3) American Indian or Alaska Native 
4) Asian 
5) Native Hawaiian or Pacific Islander 
6) Other 
Nominal   
Ethnicity  1) Hispanic (Spanish or Latino) 
2) Non-Hispanic 
Binary  




1) back pain  
2) irritable bowel syndrome  
3) migraine  
4) non-migraine headaches  
5) fibromyalgia  
6) neck pain  
7) pelvic pain occurring outside of menstrual period  
8) interstitial cystitis  
9) other chronic pain not listed above 




1) endometriosis  
2) uterine fibroids  
3) bacterial vaginosis  
4) polycystic ovary syndrome  




Perceived Stress Scale 10 items each with 6-point ordinal (0-5) Interval Total score  
(Possible range: 0-50) 
PROMIS Depression Short 
Form 
8 items each with 5-point ordinal (1-5)  Interval PROMIS T Score  
(Possible range: 35-82) 
PROMIS Anxiety Short 
Form 
8 items each with 5-point ordinal (1-5) Interval PROMIS T Score  
(Possible range: 37-83) 
PROMIS Sleep 
Disturbance Short Form 
8 items each with 5-point ordinal (1-5) Interval PROMIS T Score  
(Possible Range: 29-77) 




13 Items each with 5-point ordinal (0-4) Interval Total score  
(Possible range: 0-52) 




Sample Demographic, Clinical, and Psycho-behavioral Characteristics (N=678) 
 
 Mean ± SD  
 
n (%) 
Age (Mean ± SD) 28.0 ± 7.6  
Years with dysmenorrhea  15.8 ± 7.7  
Race   
 White   459 (67.7%) 
Black or African American   90 (13.3%) 
Asian  53 (7.8%) 
Other   76 (11.2%) 
Ethnicity Hispanic   82 (12.1%) 
Number of Comorbid Chronic Pain Conditions  1.1 ± 1.4  
Bacterial Vaginosis   62 (9.1%) 
Endometriosis   33 (4.9%) 
Polycystic Ovary Syndrome   33 (4.9%) 
Uterine Fibroids   21 (3.1%) 
Perceived Stress  22.4 ± 6.4  
Anxiety T-score  62.3 ± 8.8  
Depression T-score  57.1 ± 9.7  
Sleep Disturbance T-score  51.6 ± 4.0  






























Model with Demographic, Clinical, 





































9 (1.3) 8 (1.2) 262 (38.6) 5 (0.7) 4 (0.6) 270 (39.8) 
Note. Perfect agreement between model without covariate and model with demographic and clinical covariates = 
94.2%. Perfect Agreement between model without covariate and model with demographic, clinical, 
and psycho-behavioral covariates=94.1% 
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Table 4 
Associations between Dysmenorrhea Symptom-based Phenotypes and Demographic, Clinical, and Psycho-behavioral Variables 
Using Latent Class Analysis with Covariates (N=678) 
  
  
“Severe Multiple Symptoms” 
vs  
“Mild Localized Pain” 
“Severe Localized Pain” 
vs  
“Mild Localized Pain” 
“Severe Multiple Symptoms” 
 vs  




Interval Odds Ratio 
95% 
Confidence 




Age 0.960 (0.810, 1.137) 0.905 (0.773, 1.060) 1.060 (0.883, 1.272) 
Black  2.427* (1.036 5.683) 0.641 (0.258, 1.595) 3.785** (1.495, 9.583) 
Asian 0.778 (0.288 2.100) 0.444 (0.144, 1.366) 1.751 (0.492, 6.234) 
Other race 1.035 (0.417 2.569) 1.240 (0.534, 2.880) 0.835 (0.320, 2.182) 
Associates degree or Higher 1.130 (0.638 2.002) 1.096 (0.628, 1.915) 1.030 (0.567, 1.873) 
Hispanic 1.633 (0.721 3.699) 0.551 (0.203, 1.494) 2.962 (0.910, 9.640) 
Years Dysmenorrhea 1.077 (0.913 1.271) 1.130 (0.966, 1.322) 0.953 (0.794, 1.144) 
Number of chronic pain conditions 1.592** (1.216 2.086) 1.438* (1.088, 1.900) 1.107 (0.912, 1.345) 
Bacterial Vaginosis 0.410 (0.162 1.040) 0.624 (0.263, 1.483) 0.656 (0.274, 1.570) 
Endometriosis 14.775* (1.594 136.967) 9.814 (0.972, 99.060) 1.505 (0.575, 3.941) 
Polycystic Ovary Syndrome 0.559 (0.139 2.250) 0.516 (0.140, 1.905) 1.083 (0.254, 4.629) 
Uterine fibroids 0.830 (0.218 3.166) 1.161 (0.275, 4.911) 0.715 (0.190, 2.696) 
PSS Total 0.982 (0.920 1.048) 1.030 (0.968, 1.095) 0.954 (0.891, 1.022) 
PROMIS Anxiety T-score 1.036 (0.980 1.095) 1.042 (0.990, 1.098) 0.994 (0.937, 1.054) 
PROMIS Depression T-score 0.966 (0.927 1.008) 0.981 (0.938, 1.025) 0.985 (0.940, 1.033) 
PROMIS Sleep T-score 1.061 (0.987 1.140) 1.006 (0.938, 1.080) 1.054 (0.981, 1.134) 
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Pain Catastrophizing total 1.062*** (1.035 1.090) 1.017 (0.992, 1.043) 1.044** (1.016, 1.073) 
Note, *p-value < .05, **p-value < .01, ***p-value < .001 
